Jan-20 -

Leukemia Group

EORTC 06863 – A randomized phase III study of autologous bone marrow transplantation versus intensive consolidation during first complete remission in acute myelogenous leukemia (AML-8A).

EORTC published the final, long-term follow-up results of the AML-8A study, which began in 1995. Results confirmed the efficacy of bone marrow transplant, compared to intensive chemotherapy, in improving disease-free survival in younger adult patients with acute myelogenous leukemia (AML) after complete remission.